R

Ray Therapeutics, Inc.

8 employees

Ray Therapeutics is a biotech company developing optogenetic gene therapies for patients with blinding diseases.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Therapeutics

Date founded

2021

Funding rounds raised

Total raised

$100M

from 3 investors over 3 rounds

R

Ray Therapeutics, Inc. raised $100M on May 16, 2023

Investors: Wu Capital （双湖资本）, Norwest Venture Partners and Novo Holdings

FAQ